Pharma Professionals Of The Decade At
5th Annual Pharmaceutical Leadership Awards To Recognize Shining
Stars Of Indian Healthcare Industry
Pfizer’s Kewal Handa, GSK’s’s Dr Hasit
Joshipura, Abbott’s Sudarshan Jain, Ranbaxy’s Arun Arun Sawhney, Emcure’s Satish
Mehta, Sanofi Aventis’s Dr. Shailesh Ayyangar, & Microlab’s
Ashok jain, to receive the coveted title at 5th Annual
Pharmaceutical Leadership Summit & Business Leadership Awards 2012
Maharashtra, Mumbai, Friday, 17th August 2012:
Indian Pharmaceutical & Biotech Industry over the years has evolved out in
the global map as the leading destination & manufacturing hub for sourcing
pharmaceutical API’s & Formulations. Indian Pharmaceutical Sector has the
distinction of being one of the most preferred location for export of
pharmaceutical products at affordable prices. Indian pharmaceutical industry is
poised to grow at the rate of 18 per cent by the year 2016-17, the Parliament
was informed today. "According to the Report of the Working Group on Drugs
and Pharmaceuticals Industry for XII Five Year Plan, the projected rate of
growth for Indian Pharmaceutical industry is envisaged as 18 per cent by
2016-17," Minister of State for Chemicals and Fertilizers Srikant Kumar
Jena said in a written reply to Indian Parliament. The projected rate of growth
of the industry in domestic market has been envisaged as 21 per cent and the
projected growth rate in the international market has been envisaged as 16 per
cent, he added. "The estimated value of business of the Pharmaceuticals
Industry in 2008 was Rs 80,300 crore which reached to Rs 1,04,209 crore in
March 2010," Jena said.
Undoubtedly, the robust growth of
Indian Pharmaceutical Industry in India as well as in abroad would not have
been possible without the visionary leadership & farsighted outlook of the
mentors, professionals of the Industry. “There are many who made it possible
for translating the ideas into action, the dreams into reality & local into
global said Satya Brahma, Chairman, Organising Committee of 5th
Annual Pharmaceutical Leadership Summit & Awards 2012 ( www.asiapharmaleaders.com ), however, we
decided to nominate the contemporary leaders with a strong visionary
professionals who transformed Indian Healthcare Industry in many ways both to
the Industry in general & their respective Company in particular as “Pharma Professionals of The Decade
2012”.
Those who will don the mantle
& will be felicitated at the glittering Award Ceremony on 21st
September in Mumbai at the Pharmaleaders’s ( www.pharmaleaders.co.in ) in association
with Pharmexcil. India Brand Equity Foundation (IBEF) under the support from
Ministry of Industry & Commerce, Government of India. are Pfizer’s Kewal
Handa, GSK’s’s Dr Hasit Joshipura, Abbott’s Sudarshan Jain, Ranbaxy’s Arun Arun
Sawhney, Emcure’s Satish Mehta, Sanofi Aventis’s Dr. Shailesh Ayyangar &
Microlab’s Ashok jain” added Satya Brahma in a News Release. Kewal Handa
who will retire from the Board Members of Pfizer India & Wyeth will receive
the coveted Title Transformational Pharma Leader of the Decade for his
outstanding contribution to the Indian Healthcare Industry & changing the
business landscape of Pfizer India’s presence in india & making it as the
leading company in healthcare business.
5th Annual
Pharmaceutical Leadership Summit & Business Leadership Awards 2012 are
running on a theme Brand India, Beyond Generics – Growth, Development &
Diversifications.
His Excellency, Governor of Maharashtra, Shri Kateekal
Sankaranarayanan in the presence of distinguished, dignitaries will give
away the coveted Awards to the shingning stars of Indian Healthcare Sector such
as Pfizer’s Kewal Handa, GSK’s’s Dr Hasit Joshipura, Abbott’s Sudarshan Jain,
Ranbaxy’s Arun Arun Sawhney, Emcure’s Satish Mehta, Sanofi Aventis’s Dr.
Shailesh Ayyangar, & Microlab’s Ashok jain at the glittering
Award Night in a suburban Hotel in Mumbai on Friday, 21st September 2012.
No comments:
Post a Comment